AFC Gamma (NASDAQ:AFCG) Director Acquires $76,250.00 in Stock
AFC Gamma (NASDAQ:AFCG) Director Leonard Tannenbaum acquired 25,000 shares of the company's stock for $76,250 on December 11th, increasing his total holdings to 5,861,098 shares. The company's stock traded down $0.23 to $3.29, with a market capitalization of $74.32 million, following a recent earnings miss. Analysts currently hold an average "Reduce" rating with a price target of $5.75 for AFCG.
Leonard Tannenbaum Purchases 20,000 Shares of AFC Gamma (NASDAQ:AFCG) Stock
Leonard Tannenbaum, a director at AFC Gamma (NASDAQ:AFCG), recently purchased 20,000 shares of the company's stock for $60,600, increasing his total holdings to over 5.8 million shares. This insider buying comes despite the company missing recent earnings estimates and receiving a consensus "Reduce" rating from analysts with an average price target of $5.75. AFC Gamma also pays a quarterly dividend of $0.15, leading to a high annualized yield of approximately 19.5%.
AFC Gamma (NASDAQ:AFCG) Director Leonard Tannenbaum Purchases 24,000 Shares of Stock
AFC Gamma Director Leonard Tannenbaum bought 24,000 shares of the company's stock on December 9th at an average price of $2.83, increasing his direct holdings to 5,816,098 shares. The purchase, valued at $67,920, was disclosed in an SEC filing. AFC Gamma has recently faced challenges, including missing quarterly earnings estimates and reporting a negative net margin, and analysts currently hold a "Reduce" rating on the stock with an average target price of $5.75.
Insider Buys Additional US$155k In Advanced Flower Capital Stock
Advanced Flower Capital Inc. (NASDAQ:AFCG) Executive Chairman, Leonard Tannenbaum, recently purchased US$155k worth of stock at US$2.87 per share. This adds to a previous larger purchase of US$2.2m made when the share price was higher. Insiders own 28% of the company, suggesting confidence despite a recent loss.
Insider Buying: AFC Gamma (NASDAQ:AFCG) Director Buys 46,000 Shares of Stock
AFC Gamma (NASDAQ:AFCG) Director Leonard Tannenbaum purchased 46,000 shares of the company's stock on December 3rd, 2025, increasing his direct stake to over 5.79 million shares. The purchase, valued at $135,240, was made at an average price of $2.94 per share. The company recently reported Q3 earnings per share of $0.16, missing estimates, and pays a quarterly dividend of $0.15.
AFC Gamma (NASDAQ:AFCG) Director Leonard Tannenbaum Buys 39,000 Shares
AFC Gamma (NASDAQ:AFCG) Director Leonard Tannenbaum recently purchased 39,000 shares of the company's stock for $111,930, increasing his total holdings to over 5.7 million shares. Despite this insider buying, the company faces challenges including missed earnings estimates, a negative net margin, and mostly "Hold/Reduce" analyst ratings with an average target price of $5.75, contrasting with a high annualized dividend yield of about 20.3%.
Leonard Tannenbaum Buys 15,000 Shares of AFC Gamma (NASDAQ:AFCG) Stock
Leonard Tannenbaum, a director at AFC Gamma (NASDAQ:AFCG), purchased 15,000 shares of the company's stock on December 1st at $2.88 per share, increasing his direct ownership to over 5.7 million shares. AFCG's stock traded up $0.08 on Wednesday, hitting $2.96, despite the company missing its Q3 EPS estimates and reporting negative net margin and revenue. The company pays an annualized dividend of $0.60, yielding approximately 20.3%, but analysts currently have a consensus "Reduce" rating with an average target price of $5.75.
Judge Lets Advanced Flower AFC Contract Breach Suit Proceed in High-Stakes Cannabis Loan Clash
A New Jersey federal judge has allowed a cannabis company's lawsuit against its lender, Advanced Flower Capital Inc. (AFC), to proceed. The lawsuit alleges AFC fabricated a loan default to seize nearly $2 million. This ruling is part of a larger ongoing dispute, with both sides accusing the other of financial misconduct and attempts to take control of assets.
AFC Gamma, Inc. Hits New 52-Week Low at $2.52 Amidst Declining Performance
AFC Gamma, Inc. has reached a new 52-week low of USD 2.52, down significantly from its 52-week high of USD 9.93, reflecting a 69.43% stock price drop over the past year. The company has reported negative financial results for three consecutive quarters, including a decrease in net sales and low operating cash flow, with a current market capitalization of USD 103 million. These struggles are evident in its negative return on equity and its underperformance compared to the S&P 500.
AFC Gamma, Inc. Hits New 52-Week Low at $2.69 Amid Declining Performance
AFC Gamma, Inc. has reached a new 52-week low of $2.69, reflecting a significant decline in performance with a 66.89% drop from its 52-week high. The microcap company, with a market capitalization of USD 103 million, is facing challenges including declining net sales, consecutive quarterly losses, negative return on equity, and low operating cash flow. These financial metrics highlight the ongoing difficulties for AFC Gamma in the current market.
Afc Gamma, Inc. Reports Q3 2025 Financial Results
AFC Gamma, Inc. (AFCG) reported a significant net loss of $12.5 million in Q3 2025, a steep decline from a net income of $1.4 million in the prior year, with interest income also decreasing. This financial downturn is attributed to reduced net interest income, a decrease in total assets, and a substantial increase in credit loss reserves. Despite these challenges, the company plans strategic expansions, including a potential conversion to a business development company, and diversification of its investment portfolio beyond the cannabis sector.
Advanced Flower Capital Inc. Announces Financial Results for the Third Quarter 2025
Advanced Flower Capital Inc. (AFC) announced a GAAP net loss of $(12.5) million and Distributable Earnings of $3.5 million for Q3 2025. Shareholders approved the company's conversion from a mortgage REIT to a Business Development Company (BDC), which is expected to expand investment opportunities beyond real estate-backed loans in the cannabis market. The company also declared a cash dividend of $0.15 per common share for the quarter.
AFC Gamma, Inc. Stock Plummets to New 52-Week Low of $3.18
AFC Gamma, Inc. (ticker not provided) has reached a new 52-week low of $3.18, experiencing a 61.33% stock price decline over the past year. The company, a microcap in the finance sector, faces a precarious financial position due to decreasing net sales, negative quarterly results, a low P/E ratio of 6.00, and negative return on equity. Its performance has consistently underperformed the S&P 500, raising concerns about its market viability.
AFC Gamma (NASDAQ:AFCG) Stock Price Down 0.6% - What's Next?
AFC Gamma's stock price dropped by 0.6% to $3.40, with trading volume also down. Analysts have downgraded the stock to a "hold" with a consensus price target of $5.75, while the company declared a quarterly dividend yielding 17.6% despite a negative payout ratio. Insider transactions indicate recent share acquisitions by its director and CEO.
AFC Gamma Inc. (NASDAQ:AFCG) Given Consensus Rating of "Hold" by Brokerages
AFC Gamma Inc. (NASDAQ:AFCG) has received a consensus "Hold" rating from five brokerages with an average price target of $5.75 per share. Recent insider buying by Director Leonard M. Tannenbaum and CEO Daniel Neville indicates confidence, while the company also declared a quarterly dividend of $0.15, representing a 15.3% annualized yield.
Advanced Flower Capital Announces Dividend for the Third Quarter 2025
Advanced Flower Capital Inc. (Nasdaq: AFCG) has declared a quarterly dividend of $0.15 per outstanding share of common stock for the third quarter of 2025, payable on October 15, 2025. This dividend is consistent with the previous quarter's dividend. The company's Board of Directors evaluates Distributable Earnings quarterly to determine dividend levels, especially given uncertainties regarding loan repayments.
AFC Gamma AFCG Q2 2025 Earnings Call Transcript
AFC Gamma (AFCG) announced its Q2 2025 earnings and detailed plans to convert from a REIT to a Business Development Company (BDC), pending shareholder approval, to expand its lending opportunities beyond real estate-backed assets. The company reported distributable earnings of $0.15 per share and discussed challenges with legacy underperforming loans and the ongoing impact of capital scarcity in the cannabis industry. Management highlighted the potential benefits of BDC conversion for diversification and addressing the limitations of REIT-compliant investments in the current market.
AFC Gamma Inc. (AFCG) Misses Q2 Earnings and Revenue Estimates
AFC Gamma Inc. (AFCG) reported Q2 earnings of $0.15 per share, missing the Zacks Consensus Estimate of $0.24, and revenues of $6.2 million, falling short of the $7.57 million consensus. The company's shares have declined by 45.3% year-to-date, underperforming the S&P 500. The article also touches on the outlook for Ellington Credit (EARN), another company in the same industry.
AFC Gamma cuts dividend, shares drop most since March
AFC Gamma (AFCG) shares dropped significantly after the company announced a second consecutive quarterly dividend cut, reducing it to 15 cents per share from 23 cents. This decision was primarily attributed to a realized loss from a loan to "Public Company A." Following the news, Zuanic Group downgraded AFC Gamma's stock rating to neutral from overweight.
Cannabis firm Standard Wellness unlocks $14 million in new financing
Standard Wellness Holdings, a Cleveland-based multistate cannabis company, has secured a $14 million senior secured credit facility from Advanced Flower Capital Inc. This financing will be used to pay off existing debt from Focus Growth Capital Partners and a seller note with Columbia Care, and to support the acquisition of a new dispensary in St. Louis. The deal, which features a 12.5% interest rate, signifies the company's growth and financial management, especially given the challenges of financing in the cannabis industry.
Advanced Flower Capital Provides $15 Million Senior Secured Credit Facility to Story Ohio
Advanced Flower Capital (AFC) has provided a $15 million senior secured credit facility to Story of Ohio LLC, a subsidiary of Story Companies. This funding will support Story's expansion efforts, specifically for acquiring and building out dispensaries in the growing Ohio adult-use cannabis market. AFC will hold the entire credit facility, secured by Story of Ohio LLC's assets, including cannabis licenses and real estate in Ohio and Georgia.
Advanced Flower Capital Provides $15 Million Senior Secured Credit Facility to Story Ohio
Advanced Flower Capital Inc. has committed and funded a $15 million senior secured credit facility to Story of Ohio LLC, the Ohio subsidiary of Story Companies. This funding will support Story's expansion efforts by acquiring and building out dispensaries in Ohio's growing adult-use cannabis market. AFC CEO Daniel Neville highlighted Story's strong execution in a volatile market, while Story CEO Jason Vedadi expressed enthusiasm for continued collaboration with AFC.
AFC Gamma, Inc. (NASDAQ:AFCG) Q3 2024 Earnings Call Transcript
AFC Gamma, Inc. (AFCG) reported its Q3 2024 earnings, highlighting a strong quarter with $59 million in new loan originations, exceeding its annual target with $116 million year-to-date. The company, now a pure-play cannabis mortgage REIT after a spin-off, discussed its strategy to capitalize on limited access to capital in the cannabis sector, anticipating slower federal reform, and maintaining a diversified portfolio with an 18% weighted average yield to maturity. Executives expressed confidence in their ability to deploy capital into quality credits despite market choppiness and an expected prolonged stagnation period for certain cannabis markets.
AFC Gamma spins off real estate portfolio into new REIT
AFC Gamma, Inc. has successfully spun off its commercial real estate portfolio into a new, publicly-traded REIT called Sunrise Realty Trust, Inc. (Nasdaq: SUNS). This strategic move allows AFC Gamma to concentrate on its core business, while Sunrise Realty Trust gains independence to pursue its own growth, with existing AFC Gamma shareholders receiving shares in the new entity. The company also reported strong Q1 2024 earnings and maintains a significant dividend yield.
Earnings call: AFC Gamma reports solid Q1 2024 performance
AFC Gamma, Inc. (NASDAQ: AFCG) announced solid Q1 2024 results, reporting distributable earnings of $0.49 per share and declaring a $0.48 dividend per share for the fourth consecutive quarter. The company remains optimistic about the cannabis industry's growth, driven by state-level legalization and potential federal reclassification, and highlighted successful portfolio management and a strong pipeline for new deals. AFC Gamma is also progressing with the spin-off of its commercial real estate portfolio into Sunrise Realty Trust, expected by mid-2024, to further streamline operations and unlock shareholder value.
AFC Gamma Finances Florida Cannabis Company
AFC Gamma has provided $34.0 million in debt capital to High End Holdings, LLC and Green Sentry Holdings, LLC, operating as Sunburn Cannabis, a vertically integrated Florida operator. The funding will be used by Sunburn to refinance existing debt, provide working capital, and expand its cultivation, processing facilities, and retail dispensaries. This transaction marks AFC Gamma's second Venture into Florida's medical cannabis market, highlighting Sunburn's strong positioning for market share growth.
AFC Gamma, Inc. Schedules Fourth Quarter and Annual 2023 Earnings Conference Call for March 7, 2024
AFC Gamma, Inc. announced its Q4 and annual 2023 earnings conference call for March 7, 2024, at 10:00 AM ET. The company will report earnings for the quarter and fiscal year ended December 31, 2023, on the same day. Interested parties can access the live audio webcast via AFC Gamma’s website or register in advance for telephone participation.
Whittier Daily News: Local News, Sports, Things to Do - AFC Gamma Announces Fourth Quarter 2023 Dividend
AFC Gamma, Inc. (NASDAQ: AFCG) announced a quarterly dividend of $0.48 per outstanding share of common stock for the quarter ending December 31, 2023. The dividend is payable on January 12, 2024, to stockholders of record on December 31, 2023, and is consistent with the previous quarter's dividend. AFC Gamma is an institutional lender specializing in loans secured by commercial real estate, including cannabis operators.
AFC Gamma, Inc. Announces Financial Results for First Quarter 2023
AFC Gamma, Inc. announced its financial results for the first quarter of 2023, reporting GAAP net income of $10.0 million ($0.49 per share) and Distributable Earnings of $11.6 million ($0.57 per share). The company also declared a dividend of $0.56 per common share for the quarter, repurchased $10.0 million in 2027 Senior Notes, and appointed Brandon Hetzel as its new Chief Financial Officer.
Financing the Cannabis Industry Part 1: A Q&A with AFC Gamma CEO & Partner Len Tannenbaum
This article features a Q&A with Len Tannenbaum, CEO & Partner at AFC Gamma, discussing the challenges and trends in financing the cannabis industry. Tannenbaum elaborates on AFC Gamma's lending philosophy, the types of companies they finance, and the impact of capital market dynamics and potential legislative changes like the SAFE Banking Act on their business. He also highlights key trends in state-level legalization and cannabis pricing they are monitoring.
Cannabis Lender AFC Gamma Sees The Future Of Cannabis Banking As ‘Wide Open’
AFC Gamma, a commercial mortgage REIT, is a major institutional lender providing financial solutions to the cannabis industry, which traditionally lacks access to capital. Co-founders Len and Robyn Tannenbaum discuss their approach to lending, focusing on limited-license states and building long-term relationships with diverse operators, from large MSOs to smaller single-state businesses. They also touch upon their strategy for a diverse portfolio, the potential impact of the SAFE Banking Act, and their excitement for certain state markets like Ohio and New York.
Cannabis Mortgage REIT AFC Gamma Boosts Nature’s Medicines Funding to $62.5 Million
AFC Gamma, Inc. has expanded its senior credit facility to Devi Holdings Inc., operating as Nature’s Medicines, by an additional $30 million, increasing the total commitment to $62.5 million. This funding aims to support Nature’s Medicines' strategic acquisitions and business expansion across its multi-state operations. The move highlights AFC Gamma's strategy of fostering long-term relationships with growing cannabis businesses.
AFC Gamma Provides Business Update
AFC Gamma, a commercial real estate finance company specializing in the cannabis industry, announced significant business updates for the quarter ended June 30, 2021. The company reported $77.8 million in gross funding and was added to the Russell 2000® Index, along with receiving an investment grade rating of BBB- from Egan-Jones Ratings Company. These achievements highlight AFC Gamma's strengthened position as a leader in cannabis lending and its increased visibility within the investment community.
Cannabis Industry Lender AFC Gamma Looks Ahead to $500M Actionable Pipeline
AFC Gamma CEO Leonard Tannenbaum discusses the company's significant growth since its NASDAQ IPO, expanding its deal flow to an actionable pipeline of $500 million. The company focuses on lending to cash-flow supported, limited-license state operators and large MSOs, with recent investments in states like New Jersey, Ohio, and Texas. Tannenbaum also touched upon the prospect of federal cannabis legalization and its impact on the industry.
AFC Gamma Provides Justice Cannabis Co. With $22 Million Senior Secured Credit Facility to Fund its New Jersey Expansion
AFC Gamma has provided a $22 million senior secured credit facility to Justice Cannabis Co. to fund its expansion in New Jersey. This financing will support the purchase and build-out of a 72,000 square foot cultivation and processing facility and a dispensary in Ewing, NJ, marking AFC Gamma's first transaction in New Jersey's expanding medical and adult-use marijuana market. Both companies express enthusiasm for capitalizing on the growing cannabis market in New Jersey.
AFC Gamma Prices Initial Public Offering
AFC Gamma, Inc. announced the pricing of its initial public offering of 6,250,000 shares of common stock at $19.00 per share, anticipating gross proceeds of approximately $118.8 million. The Company's common stock is set to begin trading on The Nasdaq Global Market under the ticker symbol "AFCG" on March 19, 2021. Proceeds from the offering will be used to fund loans, originate additional commercial loans, repay existing borrowings, and for working capital and general corporate purposes.
Advanced Flower Capital Announces the First Closing of its Cannabis Mortgage Real-Estate Investment Trust
Advanced Flower Capital (AFC Gamma Inc.), a commercial-mortgage REIT, has completed the first closing of its $200 million investment vehicle, raising approximately $80 million from over 20 family offices. Additionally, AFC Gamma has secured a credit line of up to $40 million, providing a total capacity of $120 million to lend to cannabis operators. The company has already funded about $50 million across five borrowers and committed an additional $30 million, aiming to address the capital access challenges faced by the cannabis industry.
